Kodiak Sciences Inc Common Stock

KOD

...

KOD: Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Show KOD Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of KOD by members of U.S. Congress

Politician	Type	Traded
Christopher L. Jacobs House / R	Sale $1,001 - $15,000	Nov. 08, 2022
Christopher L. Jacobs House / R	Purchase $1,001 - $15,000	Jul. 18, 2022

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by KOD's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on KOD's company Twitter account

WallStreetBets

Number of mentions of KOD in WallStreetBets Daily Discussion

KOD News

Recent insights relating to KOD

CNBC Recommendations

Recent picks made for KOD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KOD

Corporate Flights

Flights by private jets registered to KOD